BioWorld

Sep. 8, 2008

Spin-Outs Offer Biotech Creative Financing Option

As of the end of August, biotech companies had raised $8.1 billion this year, less than half of the $19.3 billion raised in the same period last year, according to data from BioWorld Financial Watch. (BioWorld Financial Watch) Read More

Money Raised Year to Date

Stock Winners and Losers For The Week

Public Financing of Biotechnology: August 2008

Other Financings of Public Biotechnology Companies: August 2008

Venture Capital and Other Investments in Private Biotechnology Companies: August 2008

Milestone Payments from Corporate Partners: August 2008

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for Dec. 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 31, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...